Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study.
Gupta PK, Maheshwari S, Cherian JJ, Goni V, Sharma AK, Tripathy SK, Talari K, Pandey V, Sancheti PK, Singh S, Bandyopadhyay S, Shetty N, Kamath SU, Prahaldbhai PS, Abraham J, Kannan S, Bhat S, Parshuram S, Shahavi V, Sharma A, Verma NN, Kumar U. Gupta PK, et al. Am J Sports Med. 2023 Jul;51(9):2254-2266. doi: 10.1177/03635465231180323. Epub 2023 Jun 27. Am J Sports Med. 2023. PMID: 37366164 Clinical Trial.
Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint.
Gupta PK, Chullikana A, Rengasamy M, Shetty N, Pandey V, Agarwal V, Wagh SY, Vellotare PK, Damodaran D, Viswanathan P, Thej C, Balasubramanian S, Majumdar AS. Gupta PK, et al. Arthritis Res Ther. 2016 Dec 20;18(1):301. doi: 10.1186/s13075-016-1195-7. Arthritis Res Ther. 2016. PMID: 27993154 Free PMC article. Clinical Trial.
Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.
Gupta PK, Dutta S, Kala S, Nekkanti M, Desai SC, Mahapatra SS, Dhar A, Raju R, M R, Behera A, P S, Raviraja NS, Viswanathan P, Chandrashekar M, Thej C, K V P, Abraham J, Boggarapu H, Udaykumar K. Gupta PK, et al. Stem Cells Transl Med. 2021 Dec;10(12):1602-1613. doi: 10.1002/sctm.21-0197. Epub 2021 Sep 13. Stem Cells Transl Med. 2021. PMID: 34519179 Free PMC article. Clinical Trial.
Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease.
Gupta PK, Shivashankar P, Rajkumar M, Mahapatra SS, Desai SC, Dhar A, Krishna V, Raviraja NS, Bhat S, Viswanathan P, Kannan S, Abraham J, Boggarapu H, Manjuprasad MS, Udaykumar K. Gupta PK, et al. Stem Cell Res Ther. 2023 Apr 1;14(1):60. doi: 10.1186/s13287-023-03292-w. Stem Cell Res Ther. 2023. PMID: 37005673 Free PMC article. Clinical Trial.
1,610 results